Influence of Oreocnide integrifolia (Gaud.)‎ Miq on IRS-1, Akt and Glut-4 in Fat-Fed C57BL6J Type 2 Diabetes Mouse Model

Abstract EN

Oreocnide integrifolia (OI) leaves are used as folklore medicine by the people of northeast India to alleviate diabetic symptoms.

Preliminary studies revealed hypoglycemic and hypolipidemic potentials of the aqueous leaf extract.

The present study was carried out to evaluate whether the OI extract induces insulin secretion in vivo and in vitro and also whether it is mediated through the insulin-signaling pathway.

The experimental set-up consisted of three groups of C57BL/6J mice strain: (i) control animals fed with standard laboratory diet, (ii) diabetic animals fed with a high-fat diet for 24 weeks and (iii) extract-supplemented animals fed with 3% OI extract along with high-fat diet for 24 weeks.

OI-extract supplementation lowered adiposity and plasma glucose and insulin levels.

Immunoblot analysis of IRS-1, Akt and Glut-4 protein expressions in muscles of extract-supplemented animals revealed that glucoregulation was mediated through the insulin-signaling pathway.

Moreover, immunostaining of pancreas revealed increased insulin immunopositive cells in OI-extract-treated animals.

In addition, the insulin secretogogue ability of the OI extract was demonstrated when challenged with high glucose concentration using isolated pancreatic islets in vitro.

Overall, the present study demonstrates the possible mechanism of glucoregulation of OI extract suggestive of its therapeutic potential for the management of diabetes mellitus.